CI The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.…
Industry Peers
Healthcare PlansKey Statistics
About The Cigna Group (NYSE: CI)
›
The Cigna Group (NYSE: CI) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Healthcare Plans industry, part of the Healthcare sector, and reports about 65,669 employees.
The shares were at 273.04 USD on 19 November 2026, up 1.8% over 52 weeks. Its 52-week range is 257.85 USD to 318.00 USD: the price is 14.1% below the high and 5.9% above the low.
At a market capitalisation of 71.95B USD, it trades at 12.0 times trailing earnings and 8.2 times forward earnings. The median trailing P/E of its 9 largest Healthcare Plans peers is 22.5, a discount of 47% for CI. It pays a dividend yielding 2.19% (it pays out 27% of its earnings), against a median of 2.19% among the dividend payers in that peer group.
The Cigna Group reports return on equity of 14.3%, an operating margin of 3.8% and revenue up 5.6% year over year.
Its debt exceeds its cash by 23.85B USD, a debt-to-equity ratio of 0.75. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 25 analysts cover the stock, with an average rating of Buy; their mean price target of 344.40 USD is 26.1% above the current price. The next earnings report is expected on 4 February 2027.